Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack F Shern

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Cancer Research|January 4, 2023
HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma PhenotypeMan Xu, Ming Sun, Xiyuan Zhang, et al.
JCI Insight|September 22, 2022
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironmentLeah J Kershner, Kwangmin Choi, Jianqiang Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against NeuroblastomaRosa Nguyen, Xiyuan Zhang, Ming Sun, et al.
Biorxiv : the Preprint Server for Biology|October 2, 2023
MYCN driven oncogenesis involves cooperation with WDR5 to activate canonical MYC targets and G9a to repress differentiation genesZhihui Liu, Xiyuan Zhang, Man Xu, et al.
Plos Biology|March 28, 2024
MYCN drives oncogenesis by cooperating with the histone methyltransferase G9a and the WDR5 adaptor to orchestrate global gene transcriptionZhihui Liu, Xiyuan Zhang, Man Xu, et al.
Plos One|October 15, 2013
Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534)Samuel Q Li, Adam T Cheuk, Jack F Shern, et al.
The Journal of Biological Chemistry|August 13, 2003
Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2AJack F Shern, J Daniel Sharer, David C Pallas, et al.
Pediatric Blood & Cancer|October 27, 2023
Childhood cancer data initiative: Status reportSubhashini Jagu, Elaine R Mardis, Mary F Wedekind, et al.
The Journal of Clinical Investigation|June 24, 2021
Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplificationThanh H Nguyen, Prasantha L Vemu, Gregory E Hoy, et al.
Oncotarget|May 21, 2015
Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiationTimothy McKinnon, Rosemarie Venier, Brendan C Dickson, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|January 4, 2023
HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma PhenotypeMan Xu, Ming Sun, Xiyuan Zhang, et al.
JCI Insight|September 22, 2022
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironmentLeah J Kershner, Kwangmin Choi, Jianqiang Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against NeuroblastomaRosa Nguyen, Xiyuan Zhang, Ming Sun, et al.
Biorxiv : the Preprint Server for Biology|October 2, 2023
MYCN driven oncogenesis involves cooperation with WDR5 to activate canonical MYC targets and G9a to repress differentiation genesZhihui Liu, Xiyuan Zhang, Man Xu, et al.
Plos Biology|March 28, 2024
MYCN drives oncogenesis by cooperating with the histone methyltransferase G9a and the WDR5 adaptor to orchestrate global gene transcriptionZhihui Liu, Xiyuan Zhang, Man Xu, et al.
Plos One|October 15, 2013
Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534)Samuel Q Li, Adam T Cheuk, Jack F Shern, et al.
The Journal of Biological Chemistry|August 13, 2003
Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2AJack F Shern, J Daniel Sharer, David C Pallas, et al.
Pediatric Blood & Cancer|October 27, 2023
Childhood cancer data initiative: Status reportSubhashini Jagu, Elaine R Mardis, Mary F Wedekind, et al.
The Journal of Clinical Investigation|June 24, 2021
Serine hydroxymethyltransferase 2 expression promotes tumorigenesis in rhabdomyosarcoma with 12q13-q14 amplificationThanh H Nguyen, Prasantha L Vemu, Gregory E Hoy, et al.
Oncotarget|May 21, 2015
Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiationTimothy McKinnon, Rosemarie Venier, Brendan C Dickson, et al.
Pageof 10